Today, the Innovation and Value Initiative (IVI) released public feedback on the IVI Open-Source Value Project model for rheumatoid arthritis. IVI launched the Open-Source Value Project, a first-of-its-kind effort to better measure value in health care treatments, with the release of an open-source tool focused on measuring value in treatments for RA. The IVI-RA model simulates the lifetime costs and benefits of different strategies for treating patients with moderate to severe rheumatoid arthritis, one of the costliest and most debilitating chronic diseases. IVI held an open feedback period from November 8, 2017 to February 16, 2018, to gather input from diverse health care stakeholders on the initial IVI-RA model release and the OSVP approach more broadly. The feedback received during this period are currently under review by a Technical Expert Panel, an independent panel of subject-matter experts that will provide prioritized recommendations for model revisions.
The public release of comments received is part of IVI’s overall commitment to transparency. The recommendations of the Technical Expert Panel and IVI plans for revision will similarly be made publicly available.
For more information on the IVI-RA value model or to read the full public feedback report, click on either of the buttons below.
